Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Groove Botanicals (GRVE) Gains from Investment Securities (2017)

Groove Botanicals' Gains from Investment Securities history spans 6 years, with the latest figure at $12000.0 for Q2 2015.

  • On a quarterly basis, Gains from Investment Securities fell 14.29% to $12000.0 in Q2 2015 year-over-year; TTM through Mar 2017 was -$113547.0, a 0.0% change, with the full-year FY2017 number at $53300.0, up 319.03% from a year prior.
  • Gains from Investment Securities hit $12000.0 in Q2 2015 for Groove Botanicals, up from -$125547.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for GRVE hit a ceiling of $304648.0 in Q1 2011 and a floor of -$125547.0 in Q1 2015.
  • Historically, Gains from Investment Securities has averaged $58505.9 across 5 years, with a median of $46473.0 in 2012.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 84.92% in 2012 and later surged 139.41% in 2013.
  • Tracing GRVE's Gains from Investment Securities over 5 years: stood at $304648.0 in 2011, then plummeted by 84.92% to $45946.0 in 2012, then rose by 2.29% to $47000.0 in 2013, then crashed by 70.21% to $14000.0 in 2014, then dropped by 14.29% to $12000.0 in 2015.
  • Business Quant data shows Gains from Investment Securities for GRVE at $12000.0 in Q2 2015, -$125547.0 in Q1 2015, and $14000.0 in Q2 2014.